Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Supernus Pharmaceuticals, Inc. (SUPN)

NASDAQ

$42.04

$+0.71

(+1.73%)

Pre-Market

Supernus Pharmaceuticals, Inc. (SUPN) Live Price Chart

Last updated: ⁦2026-09-16 09:45:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Supernus Pharmaceuticals, Inc. (SUPN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $42.04, with a market capitalisation of $2.41B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $40.51 to $59.68. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.41B
Open	$41.33
Day's High	$61.25
Day's Low	$4.30
Previous Close	$41.28
Volume	--
Average Volume	846.11K
P/E Ratio	--
52-Week High	$59.68
52-Week Low	$40.51
Dividend Yield	--
Earnings Date	--

Supernus Pharmaceuticals, Inc. (SUPN) Pre-Market Stock Price

Supernus Pharmaceuticals, Inc. (SUPN) is trading at $42.04 in pre-market trading as of 2026-09-16 08:14:00, up 1.84% ($0.76) from the previous close of $41.28

Pre-market trading shows how investors are pricing SUPN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Supernus Pharmaceuticals, Inc. (SUPN) 7-Day Stock Price Change

Over the past seven days, Supernus Pharmaceuticals, Inc. (SUPN) moved from $43.53 to $42.04, representing a decline of 3.43% ($1.49).

The stock traded between $40.51 and $44.11 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 604.99 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

SUPN 52-Week Price Position

Position in Range: 8.0%

52W Low$40.51

52W High$59.68

SUPN is currently trading at $42.04, placing it 8.0% of the way from its 52-week low of $40.51 to its 52-week high of $59.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Supernus Pharmaceuticals, Inc. (SUPN)?

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Supernus Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	778
Exchange	NASDAQ
Company Website	https://www.supernus.com

How to Buy Supernus Pharmaceuticals, Inc. (SUPN) Stock on MEXC

Eligible investors can buy real shares of Supernus Pharmaceuticals, Inc. (SUPN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SUPN and Place Your Order

Open the RealStocks trading page and search for SUPN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Supernus Pharmaceuticals, Inc. (SUPN) stock price today?

Supernus Pharmaceuticals, Inc. (SUPN) is currently trading at $ 42.04, up 1.84% ($0.76) from the previous close of $ 41.28. Intraday prices update in real time during regular trading hours.

2.Is SUPN stock going up or down today?

As of 2026-09-16 08:14:00, SUPN is trading at $ 42.04, up 1.84% ($0.76) from its previous close of $ 41.28. The stock has traded between $ 4.30 and $ 61.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is SUPN pre-market price?

As of 2026-09-16 08:14:00, SUPN is trading at $ 42.04 in pre-market trading, up 1.84% ($0.76) from the previous close of $ 41.28. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SUPN after-hours price?

As of 2026-09-16 08:14:00, SUPN is trading at $ 41.29 in after-hours trading, up 0.02% ($0.01) from the regular-session close of $ 41.28. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SUPN stock trading now?

SUPN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SUPN sit relative to its 52-week high and low?

Over the past 52 weeks, SUPN has traded between a low of $ 40.51 and a high of $ 59.68. At $ 42.04, the stock is positioned 8.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Supernus Pharmaceuticals, Inc. in?

Supernus Pharmaceuticals, Inc. (SUPN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Supernus Pharmaceuticals, Inc.'s market capitalisation and where is it listed?

Supernus Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 2.41B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SUPN valued in terms of P/E ratio and EPS?

SUPN trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.89. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Supernus Pharmaceuticals, Inc. pay a dividend?

Supernus Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.